FDA Inspection 1270550 — Chengdu Shuode Pharmaceutical Co., Ltd
The FDA completed an inspection of Chengdu Shuode Pharmaceutical Co., Ltd on May 9, 2025 in Chengdu. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 9, 2025
- Fiscal Year
- 2025
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Chengdu (China)